Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06644742 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PKP2-ACM Natural History Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Mar 2026 to May 15, 2026
    • Eligibility criteria expanded, about 15 words
    • Site details revised at 1 of 3 sites
  2. Primary completion date: Dec 2028 to Dec 2030v6 Show 5 more changesShow less
    • Start date: Sep 2025 to Mar 2026
    • Study completion date: Dec 2028 to Apr 2031
    • Eligibility criteria shortened, about 10 words
    • Secondary endpoints: details revised at 1 of 6 entries
    • Site details revised at 1 of 3 sites
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 3
    v5
  4. Start date: Jul 2025 to Sep 2025v4
  5. Start date: Apr 2025 to Jul 2025v3
  6. Start date: Jan 2025 to Apr 2025v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to describe the natural history and clinical events for patients who have Arrhythmogenic Cardiomyopathy with Pathogenic Plakophilin-2 Variants (PKP2-ACM) managed with standard of care.
Trial Details
NCT Number NCT06644742
Lead Sponsor Rocket Pharmaceuticals Inc.
Conditions
(from sponsor)		 Cardiomyopathies, Heart Diseases, Cardiovascular Diseases, Genetic Diseases
Related terms Arrhythmogenic Right Ventricular Dysplasia, Cardiomyopathies, Cardiovascular Diseases, Genetic Diseases, Inborn, Heart Diseases
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov